Blood Collection to Validated New Therapeutics Strategies Against Preeclampsia
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 200
Summary
- Conditions
- Preeclampsia
- Design
- Observational Model: Case-ControlTime Perspective: Prospective
Participation Requirements
- Age
- Between 18 years and 50 years
- Gender
- Only males
Description
A collection of maternal plasma and serum from patients with preeclampsia (PE) and normal pregnancy (NP) : Between 20WG and 23WG+6D : 20 patients with PE and 30 patients with NP Between 24WG and 27WG+6D : 20 patients with PE and 30 patients with NP Between 28WG and 31WG+6D : 20 patients with PE and ...
A collection of maternal plasma and serum from patients with preeclampsia (PE) and normal pregnancy (NP) : Between 20WG and 23WG+6D : 20 patients with PE and 30 patients with NP Between 24WG and 27WG+6D : 20 patients with PE and 30 patients with NP Between 28WG and 31WG+6D : 20 patients with PE and 30 patients with NP Between 32WG and 35WG+6D : 20 patients with PE and 30 patients with NP Between 36WG and 40WG+6D : 20 patients with PE and 30 patients with NP
Tracking Information
- NCT #
- NCT03188900
- Collaborators
- INSERM UMR-S 1139
- Investigators
- Study Director: Edouard Lecarpentier, MD, PhD Centre Hospitalier Intercommunal de Créteil
Get Well Soon